I was in a subculture where we thought we were redefining society. We were starting from scratch and could make our own rules.” – Betts-Lacroix, co-founder of Retro
In recent years, he has been a prolific angel investor in startups and a well-known figure in biohacking and longevity circles. He has organized and attended salons and events dedicated to longevity technologies. It was more of a hobby. That was until a series of scientific breakthroughs proved too compelling.
Retro has approximately 50 people, with teams seeking breakthroughs in autophagy (the removal of damaged cells), blood plasma rejuvenation, and three research programs related to partial cell reprogramming.
Cell reprogramming is a process in which cells from an older austria number data creature can be treated with a combination of proteins or molecules and transformed into much younger cells. It has been proven in numerous animal experiments and is based on an achievement that won a Nobel Prize.
Retro and several other startups believe it's the most promising longevity technology ever.
In Silicon Valley, more than anywhere else, people are concerned not only with slowing down aging, but also with finding real "cures" for death.
Retro believes that this time it is different: many scientists claim that the scientific task of reprogramming cells has already been solved, and now it is a question of treatments, which are purely an engineering problem. They believe that a complete change in age is not only achievable, but perhaps inevitable.
What is cell reprogramming?
In 2006, Japanese surgeon Shinya Yamanaka made a startling discovery. He took skin cells from an old mouse and turned them into stem cells. In other words, he transformed cells that the body had programmed to perform certain functions and returned them to their original state.
Yamanaka received the Nobel Prize six years after publishing his scientific paper, and the so-called Yamanaka factors are now known throughout the world of biotechnology.